The new study, based on data from nearly 1,400 PAD patients who were treated with Shockwave Medical's IVL technology, was presented at VIVA22 in Las Vegas. 

The device includes dual-sensor technology, an 11 French indwelling catheter and a flexible cannula.

The study's authors examined data from nearly 10,000 patients for a new meta-analysis, presenting their findings in JTCVS Open.

BASILICA was considered for the 67-year-old female patient, but UNICORN was seen as an overall better option. The full case study was published in Circulation: Cardiovascular Interventions.

The acquisition includes an initial investment of $35 million and an upfront closing payment of $200 million. By 2029, if the companies reach all targeted regulatory and commercial milestones, the acquisition could cost Cordis up to $1.135 billion in all.

Researchers tracked outcomes data and imaging results from nearly 4,000 TEER patients, sharing their findings in the Journal of the American College of Cardiology.

“Because patients with aortic stenosis are old and commonly have chronic kidney disease, it is essential to evaluate the renal function before TAVR," the study's authors wrote. “Albuminuria indicates glomerular injury and is an important factor in the assessment of renal function or diagnosis of chronic kidney disease."

In-hospital complications are more common among women who undergo LAAO than men. However, according to a new study in JACC: Cardiovascular Interventions, men and women have similar long-term outcomes.